A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.
Public ClinicalTrials.gov record NCT00645281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Symptom Specific Effectiveness of Tolterodine ER 4 mg in Patients With Symptoms of Overactive Bladder (OAB) in a Primary Care Setting. A Phase IV, Open-label, Single-arm, Non-randomized, Trial in Adult Patients With OAB.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of tolterodine in impacting the primary symptom or complaint of patients with OAB.
Study identification
- NCT ID
- NCT00645281
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 896 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2004
- Primary completion
- Not listed
- Completion
- Dec 31, 2004
- Last update posted
- Jan 26, 2021
2004 – 2005
United States locations
- U.S. sites
- 96
- U.S. states
- 27
- U.S. cities
- 86
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | 35211 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35213 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35234 | — |
| Pfizer Investigational Site | Huntsville | Alabama | 35801 | — |
| Pfizer Investigational Site | Montgomery | Alabama | 36117 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85051 | — |
| Pfizer Investigational Site | Sun Lakes | Arizona | 85248 | — |
| Pfizer Investigational Site | Bentonville | Arkansas | 72712 | — |
| Pfizer Investigational Site | Jonesboro | Arkansas | 72401 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72204 | — |
| Pfizer Investigational Site | Buena Park | California | 90620 | — |
| Pfizer Investigational Site | Foothill Ranch | California | 92610 | — |
| Pfizer Investigational Site | Fresno | California | 93710 | — |
| Pfizer Investigational Site | West Covina | California | 91790 | — |
| Pfizer Investigational Site | Colorado Springs | Colorado | 80904 | — |
| Pfizer Investigational Site | Lakewood | Colorado | 80228 | — |
| Pfizer Investigational Site | Chipley | Florida | 32428 | — |
| Pfizer Investigational Site | Davie | Florida | 33328 | — |
| Pfizer Investigational Site | Hallandale | Florida | 33009 | — |
| Pfizer Investigational Site | Miami | Florida | 33145 | — |
| Pfizer Investigational Site | Miami Beach | Florida | 33140 | — |
| Pfizer Investigational Site | Murdock | Florida | 33948 | — |
| Pfizer Investigational Site | Ocala | Florida | 34471 | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | 33024 | — |
| Pfizer Investigational Site | Saint Cloud | Florida | 34769 | — |
| Pfizer Investigational Site | Tampa | Florida | 33607 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30308 | — |
| Pfizer Investigational Site | Barnesville | Georgia | 30204 | — |
| Pfizer Investigational Site | Blue Ridge | Georgia | 30513 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30034 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60610 | — |
| Pfizer Investigational Site | Naperville | Illinois | 60564 | — |
| Pfizer Investigational Site | Orland Park | Illinois | 60462 | — |
| Pfizer Investigational Site | Newton | Kansas | 67114 | — |
| Pfizer Investigational Site | Shawnee Mission | Kansas | 66203 | — |
| Pfizer Investigational Site | Wichita | Kansas | 67205 | — |
| Pfizer Investigational Site | Wichita | Kansas | 67207 | — |
| Pfizer Investigational Site | Marrero | Louisiana | 70072 | — |
| Pfizer Investigational Site | Laurel | Maryland | 20707 | — |
| Pfizer Investigational Site | Oxon Hill | Maryland | 20745 | — |
| Pfizer Investigational Site | Jackson | Michigan | — | — |
| Pfizer Investigational Site | Portage | Michigan | 49002 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63117 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89128 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89146 | — |
| Pfizer Investigational Site | Blackwood | New Jersey | 08012 | — |
| Pfizer Investigational Site | Mount Laurel | New Jersey | 08054 | — |
| Pfizer Investigational Site | Binghamton | New York | 13901 | — |
| Pfizer Investigational Site | Endicott | New York | 13760 | — |
| Pfizer Investigational Site | Endwell | New York | 13760 | — |
| Pfizer Investigational Site | Kingston | New York | 12401 | — |
| Pfizer Investigational Site | Beaufort | North Carolina | 28516 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28207 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28262 | — |
| Pfizer Investigational Site | Durham | North Carolina | 27703 | — |
| Pfizer Investigational Site | Morehead City | North Carolina | 28557 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43213 | — |
| Pfizer Investigational Site | Kettering | Ohio | 45429 | — |
| Pfizer Investigational Site | Central Point | Oregon | 97502 | — |
| Pfizer Investigational Site | Medford | Oregon | 97504 | — |
| Pfizer Investigational Site | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Pfizer Investigational Site | Bensalem | Pennsylvania | 19020 | — |
| Pfizer Investigational Site | Connellsville | Pennsylvania | 15425 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19103 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19147 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19148 | — |
| Pfizer Investigational Site | Sellersville | Pennsylvania | 18960 | — |
| Pfizer Investigational Site | Stoneboro | Pennsylvania | 16153 | — |
| Pfizer Investigational Site | Warwick | Rhode Island | 02886 | — |
| Pfizer Investigational Site | Greer | South Carolina | 29651 | — |
| Pfizer Investigational Site | Simpsonville | South Carolina | 29681 | — |
| Pfizer Investigational Site | Cordova | Tennessee | 38018 | — |
| Pfizer Investigational Site | Huntingdon | Tennessee | 38344 | — |
| Pfizer Investigational Site | Lexington | Tennessee | 38351 | — |
| Pfizer Investigational Site | Savannah | Tennessee | 38372 | — |
| Pfizer Investigational Site | Selmer | Tennessee | 38375 | — |
| Pfizer Investigational Site | Waynesboro | Tennessee | 38485 | — |
| Pfizer Investigational Site | Austin | Texas | 78705 | — |
| Pfizer Investigational Site | Bryan | Texas | 77802 | — |
| Pfizer Investigational Site | Colleyville | Texas | 76034 | — |
| Pfizer Investigational Site | Friendswood | Texas | 77546 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | Plano | Texas | 75093-5841 | — |
| Pfizer Investigational Site | Plano | Texas | 75093 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78217 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84109 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84121 | — |
| Pfizer Investigational Site | West Jordan | Utah | 84084 | — |
| Pfizer Investigational Site | West Valley City | Utah | 84120 | — |
| Pfizer Investigational Site | Spokane | Washington | 99207 | — |
| Pfizer Investigational Site | Spokane | Washington | 99208 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53221 | — |
| Pfizer Investigational Site | New Berlin | Wisconsin | 53151 | — |
| Pfizer Investigational Site | Oregon | Wisconsin | 53575 | — |
| Pfizer Investigational Site | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00645281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2021 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00645281 live on ClinicalTrials.gov.